SLC1A5 and non-small cell lung carcinoma: CONCLUSIONS: miR-4652-3p blocked the inflammatory microenvironment-induced glutamine metabolic reprogramming by directly suppressing the MYC/SLC1A5 axis, thereby inhibiting NSCLC progression.